GO:0003674 | molecular_function | 54.01% (74/137) | 0.71 | 0.0 | 9.3e-05 |
GO:0044260 | cellular macromolecule metabolic process | 15.33% (21/137) | 1.54 | 1e-05 | 0.000271 |
GO:0008654 | phospholipid biosynthetic process | 2.92% (4/137) | 4.83 | 1.1e-05 | 0.000274 |
GO:0006643 | membrane lipid metabolic process | 2.92% (4/137) | 4.88 | 1e-05 | 0.000275 |
GO:0006644 | phospholipid metabolic process | 3.65% (5/137) | 4.44 | 3e-06 | 0.000291 |
GO:0003824 | catalytic activity | 34.31% (47/137) | 0.88 | 1e-05 | 0.000299 |
GO:0044238 | primary metabolic process | 23.36% (32/137) | 1.17 | 9e-06 | 0.000307 |
GO:0046467 | membrane lipid biosynthetic process | 2.92% (4/137) | 5.32 | 3e-06 | 0.000312 |
GO:0009247 | glycolipid biosynthetic process | 2.92% (4/137) | 5.32 | 3e-06 | 0.000312 |
GO:0044464 | cell part | 15.33% (21/137) | 1.56 | 9e-06 | 0.000324 |
GO:0043170 | macromolecule metabolic process | 18.98% (26/137) | 1.38 | 6e-06 | 0.00033 |
GO:0006664 | glycolipid metabolic process | 2.92% (4/137) | 5.12 | 5e-06 | 0.000338 |
GO:1903509 | liposaccharide metabolic process | 2.92% (4/137) | 4.94 | 8e-06 | 0.000352 |
GO:0006807 | nitrogen compound metabolic process | 19.71% (27/137) | 1.26 | 1.7e-05 | 0.000375 |
GO:0044424 | intracellular part | 13.87% (19/137) | 1.67 | 8e-06 | 0.000382 |
GO:0046488 | phosphatidylinositol metabolic process | 2.92% (4/137) | 4.64 | 2e-05 | 0.000414 |
GO:0006650 | glycerophospholipid metabolic process | 2.92% (4/137) | 4.59 | 2.2e-05 | 0.000417 |
GO:0005524 | ATP binding | 13.14% (18/137) | 1.62 | 2.2e-05 | 0.000436 |
GO:0046486 | glycerolipid metabolic process | 2.92% (4/137) | 4.51 | 2.8e-05 | 0.000502 |
GO:0071704 | organic substance metabolic process | 23.36% (32/137) | 1.08 | 3e-05 | 0.000512 |
GO:0008144 | drug binding | 13.14% (18/137) | 1.55 | 4.4e-05 | 0.000616 |
GO:0006497 | protein lipidation | 2.19% (3/137) | 5.42 | 4.3e-05 | 0.000636 |
GO:0006661 | phosphatidylinositol biosynthetic process | 2.19% (3/137) | 5.42 | 4.3e-05 | 0.000636 |
GO:0006506 | GPI anchor biosynthetic process | 2.19% (3/137) | 5.42 | 4.3e-05 | 0.000636 |
GO:0046474 | glycerophospholipid biosynthetic process | 2.19% (3/137) | 5.32 | 5.4e-05 | 0.000729 |
GO:0044237 | cellular metabolic process | 18.98% (26/137) | 1.15 | 9.3e-05 | 0.000956 |
GO:0006996 | organelle organization | 2.92% (4/137) | 4.08 | 9.1e-05 | 0.000968 |
GO:0004386 | helicase activity | 4.38% (6/137) | 3.08 | 8e-05 | 0.000972 |
GO:0005488 | binding | 33.58% (46/137) | 0.77 | 9e-05 | 0.000983 |
GO:0006505 | GPI anchor metabolic process | 2.19% (3/137) | 5.14 | 8e-05 | 0.001001 |
GO:0045017 | glycerolipid biosynthetic process | 2.19% (3/137) | 5.14 | 8e-05 | 0.001001 |
GO:0032559 | adenyl ribonucleotide binding | 13.14% (18/137) | 1.47 | 8.6e-05 | 0.001005 |
GO:0006259 | DNA metabolic process | 4.38% (6/137) | 3.02 | 0.000101 | 0.001008 |
GO:0044446 | intracellular organelle part | 5.84% (8/137) | 2.47 | 0.000107 | 0.001009 |
GO:0044422 | organelle part | 5.84% (8/137) | 2.47 | 0.000107 | 0.001009 |
GO:0030554 | adenyl nucleotide binding | 13.14% (18/137) | 1.47 | 8.9e-05 | 0.00101 |
GO:0036094 | small molecule binding | 15.33% (21/137) | 1.29 | 0.000122 | 0.001057 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.14% (18/137) | 1.44 | 0.000117 | 0.001071 |
GO:0009987 | cellular process | 21.9% (30/137) | 1.02 | 0.00012 | 0.001073 |
GO:0003676 | nucleic acid binding | 12.41% (17/137) | 1.47 | 0.000134 | 0.001139 |
GO:0000166 | nucleotide binding | 14.6% (20/137) | 1.29 | 0.000181 | 0.001464 |
GO:1901265 | nucleoside phosphate binding | 14.6% (20/137) | 1.29 | 0.000181 | 0.001464 |
GO:0043168 | anion binding | 14.6% (20/137) | 1.26 | 0.000246 | 0.001936 |
GO:0036211 | protein modification process | 9.49% (13/137) | 1.65 | 0.000274 | 0.002068 |
GO:0006464 | cellular protein modification process | 9.49% (13/137) | 1.65 | 0.000274 | 0.002068 |
GO:0005575 | cellular_component | 18.98% (26/137) | 1.05 | 0.000285 | 0.002103 |
GO:0032555 | purine ribonucleotide binding | 13.14% (18/137) | 1.3 | 0.000366 | 0.002641 |
GO:0008610 | lipid biosynthetic process | 3.65% (5/137) | 3.03 | 0.000382 | 0.0027 |
GO:0017076 | purine nucleotide binding | 13.14% (18/137) | 1.29 | 0.000391 | 0.002704 |
GO:0090304 | nucleic acid metabolic process | 6.57% (9/137) | 2.02 | 0.000412 | 0.00274 |
GO:0032553 | ribonucleotide binding | 13.14% (18/137) | 1.29 | 0.000407 | 0.002759 |
GO:0043412 | macromolecule modification | 9.49% (13/137) | 1.58 | 0.000435 | 0.002835 |
GO:0097367 | carbohydrate derivative binding | 13.14% (18/137) | 1.28 | 0.000448 | 0.002866 |
GO:0016740 | transferase activity | 14.6% (20/137) | 1.18 | 0.000508 | 0.003192 |
GO:0043167 | ion binding | 19.71% (27/137) | 0.94 | 0.000683 | 0.004209 |
GO:0017111 | nucleoside-triphosphatase activity | 5.84% (8/137) | 2.04 | 0.000786 | 0.004673 |
GO:0044432 | endoplasmic reticulum part | 2.19% (3/137) | 4.05 | 0.000781 | 0.004727 |
GO:0031227 | intrinsic component of endoplasmic reticulum membrane | 1.46% (2/137) | 5.47 | 0.000879 | 0.005049 |
GO:0044255 | cellular lipid metabolic process | 3.65% (5/137) | 2.77 | 0.000865 | 0.005053 |
GO:0016462 | pyrophosphatase activity | 5.84% (8/137) | 2.01 | 0.000911 | 0.005146 |
GO:0019538 | protein metabolic process | 12.41% (17/137) | 1.23 | 0.000934 | 0.005189 |
GO:0006886 | intracellular protein transport | 2.92% (4/137) | 3.2 | 0.000977 | 0.005342 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.84% (8/137) | 1.97 | 0.001068 | 0.005485 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.84% (8/137) | 1.97 | 0.001068 | 0.005485 |
GO:1901137 | carbohydrate derivative biosynthetic process | 2.92% (4/137) | 3.18 | 0.00102 | 0.005486 |
GO:0042623 | ATPase activity, coupled | 3.65% (5/137) | 2.69 | 0.001097 | 0.005552 |
GO:0044428 | nuclear part | 2.92% (4/137) | 3.16 | 0.001063 | 0.005633 |
GO:0097159 | organic cyclic compound binding | 20.44% (28/137) | 0.86 | 0.001264 | 0.006212 |
GO:1901363 | heterocyclic compound binding | 20.44% (28/137) | 0.86 | 0.001258 | 0.006272 |
GO:0016757 | transferase activity, transferring glycosyl groups | 5.11% (7/137) | 2.08 | 0.001421 | 0.006693 |
GO:0051649 | establishment of localization in cell | 2.92% (4/137) | 3.05 | 0.001408 | 0.006724 |
GO:0046907 | intracellular transport | 2.92% (4/137) | 3.05 | 0.001408 | 0.006724 |
GO:0019637 | organophosphate metabolic process | 3.65% (5/137) | 2.59 | 0.00153 | 0.007104 |
GO:0008270 | zinc ion binding | 6.57% (9/137) | 1.74 | 0.001614 | 0.007395 |
GO:0044444 | cytoplasmic part | 5.84% (8/137) | 1.87 | 0.001673 | 0.007563 |
GO:0008234 | cysteine-type peptidase activity | 2.19% (3/137) | 3.61 | 0.001921 | 0.008459 |
GO:1901564 | organonitrogen compound metabolic process | 13.87% (19/137) | 1.06 | 0.001897 | 0.008462 |
GO:0051641 | cellular localization | 2.92% (4/137) | 2.84 | 0.002397 | 0.010284 |
GO:1901360 | organic cyclic compound metabolic process | 7.3% (10/137) | 1.55 | 0.002392 | 0.010397 |
GO:0090407 | organophosphate biosynthetic process | 2.92% (4/137) | 2.83 | 0.002476 | 0.010491 |
GO:0003779 | actin binding | 1.46% (2/137) | 4.73 | 0.002513 | 0.010516 |
GO:0016787 | hydrolase activity | 12.41% (17/137) | 1.09 | 0.002582 | 0.010672 |
GO:0044267 | cellular protein metabolic process | 9.49% (13/137) | 1.29 | 0.002636 | 0.010766 |
GO:0015031 | protein transport | 2.92% (4/137) | 2.77 | 0.002899 | 0.011296 |
GO:0015833 | peptide transport | 2.92% (4/137) | 2.77 | 0.002899 | 0.011296 |
GO:0042886 | amide transport | 2.92% (4/137) | 2.77 | 0.002899 | 0.011296 |
GO:0006139 | nucleobase-containing compound metabolic process | 6.57% (9/137) | 1.61 | 0.002866 | 0.011566 |
GO:0033036 | macromolecule localization | 2.92% (4/137) | 2.72 | 0.003271 | 0.012187 |
GO:0045184 | establishment of protein localization | 2.92% (4/137) | 2.72 | 0.003271 | 0.012187 |
GO:0008104 | protein localization | 2.92% (4/137) | 2.72 | 0.003271 | 0.012187 |
GO:0051276 | chromosome organization | 1.46% (2/137) | 4.55 | 0.003233 | 0.012455 |
GO:0005515 | protein binding | 12.41% (17/137) | 1.05 | 0.003519 | 0.012968 |
GO:0071705 | nitrogen compound transport | 2.92% (4/137) | 2.66 | 0.003781 | 0.013783 |
GO:0006629 | lipid metabolic process | 4.38% (6/137) | 2.01 | 0.003938 | 0.014201 |
GO:0008565 | protein transporter activity | 1.46% (2/137) | 4.39 | 0.004039 | 0.014262 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.46% (2/137) | 4.39 | 0.004039 | 0.014262 |
GO:0008150 | biological_process | 33.58% (46/137) | 0.52 | 0.004083 | 0.01427 |
GO:0061659 | ubiquitin-like protein ligase activity | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0009029 | tetraacyldisaccharide 4'-kinase activity | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0005639 | integral component of nuclear inner membrane | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0019905 | syntaxin binding | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0000149 | SNARE binding | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0031229 | intrinsic component of nuclear inner membrane | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0061630 | ubiquitin protein ligase activity | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0034450 | ubiquitin-ubiquitin ligase activity | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0044453 | nuclear membrane part | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0004835 | tubulin-tyrosine ligase activity | 0.73% (1/137) | 7.64 | 0.005016 | 0.015458 |
GO:0004518 | nuclease activity | 2.19% (3/137) | 3.12 | 0.00508 | 0.015516 |
GO:0016887 | ATPase activity | 3.65% (5/137) | 2.15 | 0.005526 | 0.016725 |
GO:0071702 | organic substance transport | 2.92% (4/137) | 2.55 | 0.004957 | 0.016803 |
GO:0007010 | cytoskeleton organization | 1.46% (2/137) | 4.25 | 0.004927 | 0.016872 |
GO:0008152 | metabolic process | 25.55% (35/137) | 0.62 | 0.004882 | 0.016889 |
GO:0140097 | catalytic activity, acting on DNA | 2.19% (3/137) | 3.03 | 0.005944 | 0.017832 |
GO:0006725 | cellular aromatic compound metabolic process | 6.57% (9/137) | 1.43 | 0.00642 | 0.018602 |
GO:0046483 | heterocycle metabolic process | 6.57% (9/137) | 1.44 | 0.006299 | 0.018733 |
GO:0005643 | nuclear pore | 1.46% (2/137) | 4.05 | 0.006413 | 0.01874 |
GO:0008092 | cytoskeletal protein binding | 1.46% (2/137) | 4.05 | 0.006413 | 0.01874 |
GO:1901135 | carbohydrate derivative metabolic process | 2.92% (4/137) | 2.38 | 0.007477 | 0.021481 |
GO:0034061 | DNA polymerase activity | 1.46% (2/137) | 3.88 | 0.008076 | 0.022814 |
GO:0008375 | acetylglucosaminyltransferase activity | 1.46% (2/137) | 3.88 | 0.008076 | 0.022814 |
GO:0016192 | vesicle-mediated transport | 2.19% (3/137) | 2.83 | 0.00875 | 0.024515 |
GO:0031224 | intrinsic component of membrane | 5.11% (7/137) | 1.56 | 0.010026 | 0.02575 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0060249 | anatomical structure homeostasis | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0000723 | telomere maintenance | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0000781 | chromosome, telomeric region | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0000784 | nuclear chromosome, telomeric region | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0032200 | telomere organization | 0.73% (1/137) | 6.64 | 0.010007 | 0.025896 |
GO:0070035 | purine NTP-dependent helicase activity | 2.19% (3/137) | 2.76 | 0.009933 | 0.027155 |
GO:0008026 | ATP-dependent helicase activity | 2.19% (3/137) | 2.76 | 0.009933 | 0.027155 |
GO:0005783 | endoplasmic reticulum | 1.46% (2/137) | 3.73 | 0.009911 | 0.027538 |
GO:0044425 | membrane part | 5.84% (8/137) | 1.4 | 0.011473 | 0.029243 |
GO:0003677 | DNA binding | 5.84% (8/137) | 1.38 | 0.012118 | 0.030656 |
GO:0043413 | macromolecule glycosylation | 1.46% (2/137) | 3.51 | 0.013336 | 0.033243 |
GO:0006486 | protein glycosylation | 1.46% (2/137) | 3.51 | 0.013336 | 0.033243 |
GO:0018342 | protein prenylation | 0.73% (1/137) | 6.05 | 0.014973 | 0.035999 |
GO:0008318 | protein prenyltransferase activity | 0.73% (1/137) | 6.05 | 0.014973 | 0.035999 |
GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity | 0.73% (1/137) | 6.05 | 0.014973 | 0.035999 |
GO:0097354 | prenylation | 0.73% (1/137) | 6.05 | 0.014973 | 0.035999 |
GO:0016043 | cellular component organization | 2.92% (4/137) | 2.08 | 0.015295 | 0.036514 |
GO:0006260 | DNA replication | 1.46% (2/137) | 3.43 | 0.014831 | 0.036699 |
GO:0070085 | glycosylation | 1.46% (2/137) | 3.28 | 0.018024 | 0.042729 |
GO:1901271 | lipooligosaccharide biosynthetic process | 0.73% (1/137) | 5.64 | 0.019914 | 0.045615 |
GO:1901269 | lipooligosaccharide metabolic process | 0.73% (1/137) | 5.64 | 0.019914 | 0.045615 |
GO:0009245 | lipid A biosynthetic process | 0.73% (1/137) | 5.64 | 0.019914 | 0.045615 |
GO:0046493 | lipid A metabolic process | 0.73% (1/137) | 5.64 | 0.019914 | 0.045615 |
GO:0071840 | cellular component organization or biogenesis | 2.92% (4/137) | 1.97 | 0.019658 | 0.046279 |